MDNews - Lower Hudson/Bronx

May 2016

Issue link: https://viewer.e-digitaledition.com/i/674623

Contents of this Issue

Navigation

Page 9 of 23

m u l t i d i s c i p l i n a r y o n c o l o g y c a r e pr o g r a m i s l i n k e d t o t h e e x i s t i n g prog ra m at NewYork-Presby ter ia n / Columbia University Medica l Center. We follow an academic model that only ser ves to fur ther enha nce the qua lity of u rolog ic ca ncer ca re ava i lable at NewYork-Presby terian/Lawrence." Together with Dr. Benson and medical oncologist Michelle Boyar, MD, Dr. Lee and other members of the Cancer Care Team participate in Case Conferences to discuss the care of patients with urologic cancers. For those with prostate or other cancers that have advanced beyond the rea lm of active sur veilla nce or other conser vative methods of ca re, Dr. Lee will recommend a variety of treatment options, including intensity-modulated r a d i a t i o n t h e r a p y, i m a g e - g u i d e d radiation therapy, stereotactic radio- surger y a nd other forms of radiation t herapy§ moda l ities usi n g t he l i nea r accelerator (LINAC). " When our Cancer Center opens, this machine w i l l a l low us to use ima ge- g uided radiation therapy that accounts for movement a nd location like never before," Dr. Lee says. " It is the latest iteration of radiation technolog y a nd the f irst time that technolog y has been developed from the ground up to enable u s t o del iver bet t er t reat ment w it h pinpoint accuracy and ease." Dr. Lee considers convenience one of the core elements of the anticipated radiation oncolog y program at NewYork- Presby ter ia n /Law rence. The linea r accelerator is capable of delivering radi- ation therapy that is administered to the patient over a period of weeks or days by breaking up doses into fewer but higher- intensity sessions. Hypofractionated radiation therapy ta kes less time and fewer sessions, a l low ing patients to maintain more normal schedules without sacrificing the quality of care necessary to e ectively treat their cancers. "Virtually all men with prostate cancer are excellent candidates for ex terna l beam radiation therapy," Dr. Lee says. "Patients are typically able to work while they undergo treatment, as well as exer- cise, have regular diets and otherwise live norma l lives. It 's a ver y positive experience thanks to the nature of the treatment and the environment in which it is completed." Though the program will be new to NYP/ Lawrence, the radiation oncology team is highly trained and experienced in the field. The recruitment of each member was rigorous and focused on his or her expertise and compassionate care. Moreover, many are locals, increasing their investment in the well-being of the communities where they work and live. Radiation oncology will continue to adva nce at NewYork-Presby ter ia n / Lawrence. An upcoming expansion of the treatment roster — brachytherapy — intro- duces an additional element of prostate cancer treatment to the program. "In brachytherapy, we implant dozens of radioactive seeds to the prostate," Dr. Lee explains. "These seeds emit radiation Dr. Benson joined the staff of NewYork-Presbyterian Medical Group Westchester in December 2015. He's also a member of ColumbiaDoctors and is a Herbert and Florence Irving Professor of Urology. " With prostate cancer, you have to individualize care. It is one cancer for which one size certainly does not fit all." • MITCHELL C. BENSON, MD, ATTENDING PHYSICIAN, NEWYORK€PRESBYTERIAN/ LAWRENCE HOSPITAL, AND HERBERT AND FLORENCE IRVING PROFESSOR OF UROLOGY, COLUMBIA UNIVERSITY therapy directly at the site of the cancer. It can be used as a stand-alone treatment option or combined with other treat- ment modalities." While brachytherapy is technically a surgical procedure, it is completed without an incision or stitches and is considered a bloodless process. The location of the prostate makes it ideal for easy brachy- therapy seed implantation. LOOKING AHEAD By bringing in the latest advances in urolog ic ca ncer treatment as well as leaders in the field such as Dr. Benson a nd Dr. Lee, NewYork-Presby teria n/ Lawrence sends a clear message to the communities the hospital serves as well as the physicians who refer patients to the program — urologic cancer care here is adaptable, innovative and on point. The hospita l has emerged as the leader in urologic cancer detection and treatment in Westchester. "When patients enter the oncology pro- gram at NewYork-Presbyterian/Lawrence, we create a relationship that will last the rest of their lives," Dr. Killackey says. "Our teams focus on survivorship and a return to wellness. We are always here for our patients. Community outreach, risk reduction, education and collaboration with the primary care providers whose patients we care for are as essential to our mission of holistic service as treatment." For information about urologic cancer care at NewYork-Presbyterian/Lawrence Hospital , visit www.nyplawrence.org. ■ 1 0 1 0C O V E R F E A T U R E

Articles in this issue

Links on this page

Archives of this issue

view archives of MDNews - Lower Hudson/Bronx - May 2016